Table 1.

Oligonucleotide primers used for amplification and construction of scFvs

p5.2VH-1 5′-GGGGGATCCGGACTACAAGGACGACGATGACAAGATCCTAGCACAGATCCAATTGGTGCAGTCTGGACCTGAGCTG-3′ 
p5.2VH-2 5′-GCCACCGCCAGAGCCACCTCCGCCTGAACCGCCTCCACCTGTCGACGATGAGGAGACTGTGAGAGTGGTGCCTTGGCCCCAGACGG-3′ 
p5.2VL-1 5′-GGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGATCGGATATCGACATTGTGATGTCACAGTCTCCATCCTCC-3′ 
p5.2VL-2 5′-GGAGGAGGCCCCCTGGGCCCTGTTTTATTTCCAGCTTGGTCCCCCCTCCGAACGTGTACAGATTATAAGATTG-3′ 
pOKT3VH-1 5′-GGGGGATCCGGACTACAAGGACGACGATGACAAGATCTCCCAGGTCCAGCTGCAGCAGTCTGGGGCTGAACTGGCAAGA-3′ 
pOKT3VH-2 5′-GCCACCGCCAGAGCCACCTCCGCCTGAACCGCCTCCACCTGTCGACGATGAGGAGACTGTGAGAGTGGTGCCTTGGCCCCAGTAG-3′ 
pOKT3VL-1 5′-GGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGATCGGATATCCAAATTGTTCTCACCCAGTCTCCAGCAATC-3′ 
pOKT3VL-2 5′-GGAGGAGGCCCCCTGGGCCCCGGTTTATTTCCAACTTTGTCCCCGAGCCGAACGTGAATGGGTTACTACTCC-3′ 
pOKT3VH-GS 5′-GCCCAGGGGGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGATCGAAGATCTCCCAGGTCCAGCTGCAGCAGTCTGGG-3′ 
p5.2VH-1 5′-GGGGGATCCGGACTACAAGGACGACGATGACAAGATCCTAGCACAGATCCAATTGGTGCAGTCTGGACCTGAGCTG-3′ 
p5.2VH-2 5′-GCCACCGCCAGAGCCACCTCCGCCTGAACCGCCTCCACCTGTCGACGATGAGGAGACTGTGAGAGTGGTGCCTTGGCCCCAGACGG-3′ 
p5.2VL-1 5′-GGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGATCGGATATCGACATTGTGATGTCACAGTCTCCATCCTCC-3′ 
p5.2VL-2 5′-GGAGGAGGCCCCCTGGGCCCTGTTTTATTTCCAGCTTGGTCCCCCCTCCGAACGTGTACAGATTATAAGATTG-3′ 
pOKT3VH-1 5′-GGGGGATCCGGACTACAAGGACGACGATGACAAGATCTCCCAGGTCCAGCTGCAGCAGTCTGGGGCTGAACTGGCAAGA-3′ 
pOKT3VH-2 5′-GCCACCGCCAGAGCCACCTCCGCCTGAACCGCCTCCACCTGTCGACGATGAGGAGACTGTGAGAGTGGTGCCTTGGCCCCAGTAG-3′ 
pOKT3VL-1 5′-GGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGATCGGATATCCAAATTGTTCTCACCCAGTCTCCAGCAATC-3′ 
pOKT3VL-2 5′-GGAGGAGGCCCCCTGGGCCCCGGTTTATTTCCAACTTTGTCCCCGAGCCGAACGTGAATGGGTTACTACTCC-3′ 
pOKT3VH-GS 5′-GCCCAGGGGGCGGTGGAGGCGGTTCAGGCGGAGGTGGCTCTGGCGGTGGCGGATCGAAGATCTCCCAGGTCCAGCTGCAGCAGTCTGGG-3′ 

Sequences encoding (Gly4Ser)3 are underlined.

The restriction enzyme recognition sites are in italic.

Close Modal

or Create an Account

Close Modal
Close Modal